Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer.

Owen DH, Konda B, Sipos J, Liu T, Webb A, Ringel MD, Timmers CD, Shah MH.

J Natl Compr Canc Netw. 2019 May 1;17(5):409-413. doi: 10.6004/jnccn.2019.7292.

PMID:
31085763
2.

Clinical Diagnostic Evaluation of Thyroid Nodules.

Maxwell C, Sipos JA.

Endocrinol Metab Clin North Am. 2019 Mar;48(1):61-84. doi: 10.1016/j.ecl.2018.11.001. Review.

PMID:
30717911
3.

Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.

Hurst Z, Liyanarachchi S, He H, Brock P, Sipos J, Nabhan F, Kebebew E, Green P, Cote GJ, Sherman S, Walker CJ, Chang YS, Xue S, Hollingsworth B, Li W, Genutis L, Menq E, de la Chapelle A, Jhiang SM.

Thyroid. 2019 Apr;29(4):530-539. doi: 10.1089/thy.2018.0687. Epub 2019 Feb 13.

PMID:
30654714
4.

Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.

Steward DL, Carty SE, Sippel RS, Yang SP, Sosa JA, Sipos JA, Figge JJ, Mandel S, Haugen BR, Burman KD, Baloch ZW, Lloyd RV, Seethala RR, Gooding WE, Chiosea SI, Gomes-Lima C, Ferris RL, Folek JM, Khawaja RA, Kundra P, Loh KS, Marshall CB, Mayson S, McCoy KL, Nga ME, Ngiam KY, Nikiforova MN, Poehls JL, Ringel MD, Yang H, Yip L, Nikiforov YE.

JAMA Oncol. 2018 Nov 8. doi: 10.1001/jamaoncol.2018.4616. [Epub ahead of print]

5.

Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.

Owen DH, Alexander AJ, Konda B, Wei L, Hemminger JA, Schmidt CR, Abdel-Misih SRZ, Dillhoff ME, Sipos JA, Kirschner LS, Shah MH.

Oncotarget. 2017 Oct 24;8(61):104046-104056. doi: 10.18632/oncotarget.22001. eCollection 2017 Nov 28.

6.

Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.

Saporito D, Brock P, Hampel H, Sipos J, Fernandez S, Liyanarachchi S, de la Chapelle A, Nagy R.

Fam Cancer. 2018 Jul;17(3):431-434. doi: 10.1007/s10689-017-0048-0.

7.

United States and European Multicenter Prospective Study for the Analytical Performance and Clinical Validation of a Novel Sensitive Fully Automated Immunoassay for Calcitonin.

Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S, König J, Lupo MA, Raue F, Ringel MD, Sipos JA, Kratzsch J.

Clin Chem. 2017 Sep;63(9):1489-1496. doi: 10.1373/clinchem.2016.270009. Epub 2017 Jul 7.

8.

Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation.

Ling S, Bhatt AD, Brown NV, Nguyen P, Sipos JA, Chakravarti A, Rong Y.

Head Neck. 2017 Mar;39(3):548-554. doi: 10.1002/hed.24643. Epub 2016 Dec 1.

PMID:
27905164
9.

Risk Factors of 131I-Induced Salivary Gland Damage in Thyroid Cancer Patients.

Hollingsworth B, Senter L, Zhang X, Brock GN, Jarjour W, Nagy R, Brock P, Coombes KR, Kloos RT, Ringel MD, Sipos J, Lattimer I, Carrau R, Jhiang SM.

J Clin Endocrinol Metab. 2016 Nov;101(11):4085-4093. Epub 2016 Aug 17.

10.

LONG-TERM NONOPERATIVE RATE OF THYROID NODULES WITH BENIGN RESULTS ON THE AFIRMA GENE EXPRESSION CLASSIFIER.

Sipos JA, Blevins TC, Shea HC, Duick DS, Lakhian SK, Michael BE, Thomas MJ, Sosa JA.

Endocr Pract. 2016 Jun;22(6):666-72. doi: 10.4158/EP151006.OR. Epub 2016 Jan 20.

PMID:
26789352
11.

Multicenter clinical experience with the Afirma gene expression classifier.

Alexander EK, Schorr M, Klopper J, Kim C, Sipos J, Nabhan F, Parker C, Steward DL, Mandel SJ, Haugen BR.

J Clin Endocrinol Metab. 2014 Jan;99(1):119-25. doi: 10.1210/jc.2013-2482. Epub 2013 Dec 20.

PMID:
24152684
12.

Ernest L. Mazzaferri, MD, MACP (1936-2013).

Kloos RT, Sipos JA, Tzagournis M, Miyauchi A, Vaisman M, Benbassat C, Pacini F, Schlumberger M, Mazzaferri F, Jhiang SM, Gharib H, Surks M, Randolph GW, Tuttle RM.

Thyroid. 2013 Aug;23(8):917-23. doi: 10.1089/thy.2013.2308.ob.

PMID:
23964768
13.

In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin.

Valle LA, Gorodeski Baskin RL, Porter K, Sipos JA, Khawaja R, Ringel MD, Kloos RT.

Thyroid. 2013 Feb;23(2):185-93. doi: 10.1089/thy.2012.0327.

14.

Imaging of thyrotoxicosis.

Sipos JA, Kahaly GJ.

Am J Med. 2012 Sep;125(9):S1-2. doi: 10.1016/j.amjmed.2012.05.012. Review.

PMID:
22938934
15.

Graves' disease: diagnostic and therapeutic challenges (multimedia activity).

Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA.

Am J Med. 2011 Jun;124(6):S2-3. doi: 10.1016/j.amjmed.2011.03.001.

PMID:
21605717
16.

Thyroid cancer: emerging role for targeted therapies.

Sipos JA, Shah MH.

Ther Adv Med Oncol. 2010 Jan;2(1):3-16. doi: 10.1177/1758834009352667.

17.

Advances in ultrasound for the diagnosis and management of thyroid cancer.

Sipos JA.

Thyroid. 2009 Dec;19(12):1363-72. doi: 10.1089/thy.2009.1608. Review.

PMID:
20001718
18.

Do tumor characteristics predict risk of malignancy in thyroid nodules with indeterminate cytology?

Sipos JA, Ringel MD.

Nat Clin Pract Endocrinol Metab. 2009 Mar;5(3):140-1. doi: 10.1038/ncpendmet1078. Epub 2009 Feb 3.

PMID:
19190587
19.

Iodine-refractory differentiated thyroid cancer: an ominous diagnosis with the potential for a brighter future.

Sipos JA, Kloos RT.

Clin Adv Hematol Oncol. 2008 Oct;6(10):767-9. Review. No abstract available.

PMID:
18997668
20.

The therapeutic management of differentiated thyroid cancer.

Sipos JA, Mazzaferri EL.

Expert Opin Pharmacother. 2008 Oct;9(15):2627-37. doi: 10.1517/14656566.9.15.2627 . Review.

PMID:
18803450
21.
22.

Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.

Rosen CJ, Ackert-Bicknell CL, Adamo ML, Shultz KL, Rubin J, Donahue LR, Horton LG, Delahunty KM, Beamer WG, Sipos J, Clemmons D, Nelson T, Bouxsein ML, Horowitz M.

Bone. 2004 Nov;35(5):1046-58.

PMID:
15542029

Supplemental Content

Loading ...
Support Center